Reta 15 Mgs

Retatrutide (LY3437943) is a next-generation triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors simultaneously. This tri-agonist mechanism is the subject of significant research interest for its combined effects on appetite suppression, energy expenditure, and metabolic regulation — distinguishing it from dual agonists such as tirzepatide. Supplied as 15 MG lyophilised powder for laboratory research use.

• Triple agonist: GLP-1, GIP, and glucagon receptor activation
• Studied for its role in appetite regulation via central and peripheral satiety signalling
• Research interest in increased energy expenditure through glucagon receptor-mediated thermogenesis
• Investigated for metabolic health outcomes including glucose homeostasis and lipid metabolism
• 15 MG lyophilised powder — requires reconstitution with Bacteriostatic Water

Research Purposes Only This product is intended for research purposes only. Not for human consumption. Not for veterinary use. Must be handled by qualified professionals in a controlled laboratory environment.

Purity & Quality ≥99% purity. Certificate of Analysis (CoA) available upon request. All products are independently tested for quality and purity.

Storage & Handling Store lyophilised powder at -20°C. Keep away from direct sunlight and moisture. Reconstitute with Bacteriostatic Water only.